FDA Approves Abecma (idecabtagene vicleucel) as the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma

FDA Approves Abecma (idecabtagene vicleucel) as the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma PRINCETON, N.J., & CAMBRIDGE, Mass.–(BUSINESS WIRE) March 26, 2021 — Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the U.S. Food and Drug Administration (FDA) has approved Abecma (idecabtagene vicleucel;… Read More »

Virtual candlelight vigil calls for international recognition of 1971 Bangladesh genocide

International Crimes Strategy Forum or ICSF and Bangladeshi expatriates in Australia called for the virtual candlelight initiative at 00:01 hours on Thursday. The global call for candlelight vigil marked Bangladesh’s National Day of Genocide Commemoration on Mar 25, which precedes Mar 26 Independence Day. Scores of people joined in on the global call during the… Read More »